Soni Manmeet Singh, COO and CFO, Director at Summit Therapeutics Inc., bought $362K of SMMT

Soni Manmeet Singh COO and CFO, Director

Summit Therapeutics Inc. · $SMMT

$362K Total Value

25,000 Shares Traded

$14.46 Price / Share

3,098,603 Shares Owned After

2026-06-04 Filing Date

Transaction Details

Insider	Soni Manmeet Singh
Title	COO and CFO, Director
Company	Summit Therapeutics Inc.
Ticker	SMMT
Transaction Type	Purchase
Transaction Date	2026-06-04
Shares Traded	25,000
Price Per Share	$14.46
Total Value	$362K
Filed Date	2026-06-04
Accession Number	0001569769-26-000004

Ownership Context

Shares Owned After Transaction	3,098,603
Ownership Type	Direct

SEC Filing

↗ View Original SEC Filing

Accession: 0001569769-26-000004

Other Insider Trades — SMMT

Insider	Title	Action	Value	Date
DUGGAN ROBERT W	Co-Chief Executive Officer, Director, 10% Owner	bought	$50.0M	2026-06-12
Zanganeh Mahkam	Co-Chief Executive Officer, Director, 10% Owner	bought	$50.0M	2026-06-12
Zanganeh Mahkam	Co-Chief Executive Officer, Director, 10% Owner	bought	$1.5M	2026-06-04
DUGGAN ROBERT W	Co-Chief Executive Officer, Director, 10% Owner	bought	$1.5M	2026-06-04

Other Trades by Soni Manmeet Singh

Ticker	Company	Action	Value	Date
PLSE	PULSE BIOSCIENCES, INC.	traded	—	2026-06-11

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for SMMT — Summit Therapeutics Inc. →

Whisper Score — SMMT

50.0

Active Discussion

Current Whisper Score

See full analysis for SMMT →

Track SMMT insider activity in real time on The Wire →

Get alerts when Soni Manmeet Singh files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:03 UTC